Literature DB >> 15659712

Skeletal muscle contractile performance and ADP accumulation in adenylate kinase-deficient mice.

Chad R Hancock1, Edwin Janssen, Ronald L Terjung.   

Abstract

The production of AMP by adenylate kinase (AK) and subsequent deamination by AMP deaminase limits ADP accumulation during conditions of high-energy demand in skeletal muscle. The goal of this study was to investigate the consequences of AK deficiency (-/-) on adenine nucleotide management and whole muscle function at high-energy demands. To do this, we examined isometric tetanic contractile performance of the gastrocnemius-plantaris-soleus (GPS) muscle group in situ in AK1(-/-) mice and wild-type (WT) controls over a range of contraction frequencies (30-120 tetani/min). We found that AK1(-/-) muscle exhibited a diminished inosine 5'-monophosphate formation rate (14% of WT) and an inordinate accumulation of ADP ( approximately 1.5 mM) at the highest energy demands, compared with WT controls. AK-deficient muscle exhibited similar initial contractile performance (521 +/- 9 and 521 +/- 10 g tension in WT and AK1(-/-) muscle, respectively), followed by a significant slowing of relaxation kinetics at the highest energy demands relative to WT controls. This is consistent with a depressed capacity to sequester calcium in the presence of high ADP. However, the overall pattern of fatigue in AK1(-/-) mice was similar to WT control muscle. Our findings directly demonstrate the importance of AMP formation and subsequent deamination in limiting ADP accumulation. Whole muscle contractile performance was, however, remarkably tolerant of ADP accumulation markedly in excess of what normally occurs in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659712     DOI: 10.1152/ajpcell.00567.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  20 in total

Review 1.  Changes in the force-velocity relationship of fatigued muscle: implications for power production and possible causes.

Authors:  David A Jones
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

2.  Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.

Authors:  S Freeman; J B Bartlett; G Convey; I Hardern; J L Teague; S J G Loxham; J M Allen; S M Poucher; A D Charles
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

3.  Metformin activates AMP kinase through inhibition of AMP deaminase.

Authors:  Jiangyong Ouyang; Rahulkumar A Parakhia; Raymond S Ochs
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

4.  Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice.

Authors:  David M Thomson; Chad R Hancock; Bradley G Evanson; Steven G Kenney; Brandon B Malan; Anthony D Mongillo; Jacob D Brown; Squire Hepworth; Natasha Fillmore; Allen C Parcell; David L Kooyman; William W Winder
Journal:  J Appl Physiol (1985)       Date:  2010-04-01

5.  Selective inhibition of ATPase activity during contraction alters the activation of p38 MAP kinase isoforms in skeletal muscle.

Authors:  Jeffrey J Brault; Natalie M Pizzimenti; John N Dentel; Robert W Wiseman
Journal:  J Cell Biochem       Date:  2013-06       Impact factor: 4.429

Review 6.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

7.  Time course and strain dependence of ADP release during contraction of permeabilized skeletal muscle fibers.

Authors:  Timothy G West; Gabor Hild; Verl B Siththanandan; Martin R Webb; John E T Corrie; Michael A Ferenczi
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

8.  The effects of age and muscle contraction on AMPK activity and heterotrimer composition.

Authors:  Shalene E Hardman; Derrick E Hall; Alyssa J Cabrera; Chad R Hancock; David M Thomson
Journal:  Exp Gerontol       Date:  2014-04-18       Impact factor: 4.032

9.  Secretion of adenylate kinase 1 is required for extracellular ATP synthesis in C2C12 myotubes.

Authors:  Hyo-Jung Choo; Bong-Woo Kim; Oh-Bong Kwon; Chang Seok Lee; Jong-Soon Choi; Young-Gyu Ko
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

10.  Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow.

Authors:  Petras P Dzeja; Peter Bast; Darko Pucar; Be Wieringa; Andre Terzic
Journal:  J Biol Chem       Date:  2007-08-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.